Categories
News

* Brain’s chemical signals seen in real time

Neuroscientists have invented a way to watch the ebb and flow of the brain’s chemical messengers in real time. They were able to see the surge of neurotransmitters as mice were conditioned — similarly to Pavlov’s famous dogs — to salivate in response to a sound.

The study, presented at the American Chemical Society’s meeting in Philadelphia, Pennyslvania, on 22 August, uses a technique that could help to disentangle the complex language of neurotransmitters. Ultimately, it could lead to a better understanding of brain circuitry.

The brain’s electrical surges are easy to track. But detecting the chemicals that drive this activity — the neurotransmitters that travel between brain cells and lead them to fire — is much harder. “There’s a hidden signalling network in the brain, and we need tools to uncover it,” says Michael Strano, a chemical engineer at the Massachusetts Institute of Technology in Cambridge.

In many parts of the brain, neurotransmitters can exist at undetectably low levels. Typically, researchers monitor them by sucking fluid out from between neurons and analysing the contents in the lab. But that technique cannot measure activity in real time. Another option is to insert a metal probe into the space between neurons to measure how neurotransmitters react chemically when they touch metal. But the probe is unable to distinguish between structurally similar molecules, such as dopamine, which is involved in pleasure and reward, and noradrenaline which is involved in alertness.

Enter neuroscientist Paul Slesinger of the Icahn School of Medicine at Mount Sinai in New York City and neurophysicist David Kleinfeld of the University of California, San Diego. In May, they reported a method for making genetically modified human cells that produce artificial receptors for neurotransmitters. These receptors are also linked to fluorescent molecules so that when a particular neurotransmitter binds to its receptor, the cell lights up.

The researchers injected these cells, known as CNiFERs (cell-based neurotransmitter fluorescent engineered reporters) into the brains of 13 mice. Then, they cut a window into each mouse’s skull to expose its brain and put a transparent cover over the hole so that they could watch the cells light up in real time through a microscope.

Over the course of five days, the researchers trained the mice by playing a sound before giving them a sugar treat. The mice soon learned to salivate in anticipation as soon as they heard the sound. Each day, the researchers recorded light from the animals’ brains, enabling them to determine the exact moment at which neurotransmitters were released. For the first time, they could see a surge of dopamine — the pleasure molecule that drives salivation — after the sound that occurred more rapidly as the association became stronger.

Noradrenaline, a molecule involved in alertness, is also thought to surge in this type of learning, but researchers have never been able to distinguish it from dopamine in real time. But by engineering CNiFERs specific to each neurotransmitter, Slesinger and Kleinfeld showed, also for the first time, that the noradrenaline spike occured at variable times following the tone and did not change with training. This suggests that the neurotransmitter could be responding to some other factor or behavioural reaction.

The ability to use separate CNiFERs for the two neurotransmitters might eventually reveal whether noradrenalin has a role in learning and addiction, and whether drugs that target it are likely to change behaviour.

Strano says that the technique is an improvement on current methods because it quantifies neurotransmitters directly instead of calculating them through their effects. “It’s one of the purest tests you can do,” he says.

But he worries that genetically modified cells might not act the same way as natural cells. His lab is working on a set of nanotubes that cross the blood–brain barrier and emit light when they encounter a neurotransmitter in the brain.

But Lin Tian, a neuroscientist at the University of California, Davis, thinks that the technique is of limited use. The CNiFERs show whether the total amount of a molecule such as dopamine is increasing or decreasing, but they do not reveal which neuron is sending or receiving the signal — making it hard to map tangled brain circuits.

Instead, Tian and her colleagues are modifying bacterial proteins so that they bind neurotransmitters and emit light. This technique is precise enough to detect the signalling molecule glutamate in a single gap between two neurons, thus revealing the exact cells involved.

Tian says that CNiFERs might be more useful for amino-acid-based neuropeptides, such as orexin, which is involved in sleep and drug-seeking behaviours. These larger molecules are more difficult to detect with chemical techniques. Slesinger says that he and his collaborators are working on CNiFERs for this and other neuropeptides.

All of the researchers are trying to expand the repertoire of neurotransmitters that can be detected. Kleinfeld says that CNiFERS are unlikely to be used in humans any time soon because implanting cells into the brain could be dangerous. But they might be used to detect whether drugs are working in mice, and they are sensitive enough to reveal, perhaps, more subtle ways in which the brain malfunctions.

Nature doi:10.1038/nature.2016.20458

http://www.nature.com/news/index.html  Nature

http://www.nature.com/news/brain-s-chemical-signals-seen-in-real-time-1.20458 Original web at Nature

Categories
News

Imaging technique could help focus breast cancer treatment

Cancer Research UK scientists have used imaging techniques as a new way to identify patients who could benefit from certain breast cancer treatments, according to a study published in Oncotarget.

The team at King’s College London, in collaboration with scientists at the CRUK/MRC Oxford Institute for Radiation Oncology, used fluorescence lifetime imaging to confirm if they have joined together.

Fluorescent lifetime imaging is a technique that can accurately measure the distance between two protein molecules. In this study the researchers measured the distance between HER2 and HER3 proteins in breast cancer cells from patients.

The researchers think that patients whose imaging results show that these proteins have bonded together could benefit from HER2 targeted treatment, regardless of whether their tumour has high levels of HER2.

HER2 is a protein which can cause cancer cells to grow. HER2-positive breast cancer cells have high levels of the protein and can be targeted with drugs that block its effects and stop the cancer from growing — drugs being used now include Herceptin and Tykerb. Patients who could benefit from these drugs are identified by testing their cancer cells to see if they show high levels of the HER2 protein.

But this imaging technique, carried out in tumour cells, could pick up additional patients in the future who would respond well to HER2-targeting drugs. It could also confirm which patients may not be suitable for these treatments.

Lead author, Professor Tony Ng, at King’s College London and University College London, said: “This imaging technique could help us pick up patients who might benefit from these drugs but have previously been overlooked.

“Using this test, we should be able to predict which drugs won’t work in patients and avoid prescribing unnecessary treatments — putting the drugs that we’ve got to better use. The next step is to run clinical trials to see if this test could help patients.

“We hope that one day it could not only improve treatment for breast cancer but also for other cancers — including bowel and lung cancer.”

Nell Barrie, senior science information manager at Cancer Research UK, said: “There are more than 50,000 new cases of breast cancer each year but thanks to advances in research, more people survive the disease than ever before. This research could eventually give doctors another way to personalise treatment so that patients receive the drugs that are most likely to help them.”

https://www.sciencedaily.com/  Science Daily

https://www.sciencedaily.com/releases/2016/07/160707172030.htm Original web page at Science Daily

Categories
News

* 3-D-printed kidney helps doctors save woman’s organ during complicated tumor removal

Doctors and scientists at Intermountain Medical Center in Salt Lake City printed and used a 3D kidney to help save a patient’s organ during a complicated tumor-removal procedural.

The 3D-printed model allowed doctors to study the patient’s kidney in 3D to determine how to best remove the tumor as it was located in a precarious location adjacent to vital arteries and veins.

Thanks to the 3D-printed model of the organ, doctors were able to maneuver around those sensitive areas and successfully remove the tumor and ultimately save the patient’s kidney.

Linda Green’s case was particularly precarious because her tumor was in the “business section” of the kidney: near an artery, veins and the ureter. It took a multi-disciplinary team, including collaboration between doctors at Intermountain Medical Center and specialists at Intermountain Healthcare’s Transformation Laboratory, to find a solution to her unique medical problem.

Intermountain Medical Center Urological Institute director Jay Bishoff, MD, and radiologist Talmage Shill, MD, prepared CT scans to produce a 3D rendering of Green’s kidney using technology at the Intermountain Transformation Lab, a facility that is the only one of it’s kind in the Intermountain West.

Transformation Lab specialists Cory Smith and Billy Prows worked with Dr. Bishoff and Dr. Shill to render the CT scans for 3D printing. The team rendered and printed the model in two halves, so Dr. Bishoff could examine exactly how the tumor attached to the kidney. This is how he found a small nub that extended up into a pocket where the kidney collects urine.

“Without the 3-D model, the visual images of the CT scans would not have allowed us to identify this nub prior to the surgery,” he said. “The 3D printing technology allowed us to prepare a more complete plan for the patient’s surgery, show the patient the complexities of the procedure and what would be done during surgery to remove the tumor and save the kidney.”

Dr. Bishoff not only used the model to prepare for the surgery, but also brought it into the operating room to reference during the procedure. Through the multi-disciplinary team’s efforts, they managed to remove the tumor and save Green’s kidney.

“I’m just so thankful for everybody at the hospital who was involved and cared,” Green said. Dr. Bishoff was the last of many doctors to examine Green’s case, and she felt “totally confident” in his ability to perform the surgery. “It was like a night-and-day difference, and I completely trust him too. Dr. Bishoff kept me informed and called me personally, which I very much appreciated.”

The Intermountain Healthcare Transformation Lab gathers cutting-edge technologies and assembles creative and experienced personnel to advance healthcare practices.

“We’re giving doctors additional visual tools to see the anatomy in a different way,” Smith said. “In the transformation lab we talk about reimagining imaging — it’s the evolution of imaging.”

The Intermountain Urological Institute tracks urological patient outcomes to determine best practices. The institute is at the forefront of evidence-based and advanced-technological treatment methods.

“While this technology is in its infancy, it is a big step forward in using new technologies like 3D printing to improve patient care,” Dr. Bishoff said.

The institute is based at Intermountain Medical Center, which is the flagship hospital for the Salt Lake City-based Intermountain Healthcare system.

https://www.sciencedaily.com/  Science Daily

https://www.sciencedaily.com/releases/2016/06/160624100250.htm  Original web page at Science Daily

Categories
News

* ‘Camera pill’ to examine horses

Veterinary and engineering researchers at the University of Saskatchewan (U of S) have teamed up to harness imaging technology to fill in a blank area in animal health — what goes on in a horse’s gut?

“Whenever I talk to students about the horse abdomen, I put up a picture of a horse and put a big question mark in the middle,” said veterinary researcher Dr. Julia Montgomery in the U of S Western College of Veterinary Medicine. Montgomery worked with equine surgeon Dr. Joe Bracamonte and Khan Wahid, a specialist in health informatics and imaging in the College of Engineering. The team used an endoscopy capsule about the size and shape of a vitamin pill — a sort of “mini submarine” with a camera — to have a look inside a horse.

“This is really a cool way to look at the entire small intestine,” Montgomery said, explaining the only other ways are exploratory surgery or laparoscopy, which uses a thin, lighted tube inserted through an incision. Neither allows a view from inside. Veterinarians also can use an endoscope — basically a camera on the end of a thin cable — to look as far as the horse’s stomach, and a rectal exam to have a look from the other end.

Montgomery explained that capsule endoscopy offers a powerful new tool to diagnose diseases such as inflammatory bowel disease and cancer, or to check surgical sites. Researchers could use it to see how well drugs to stimulate bowel action are working, or to answer basic questions such as determining what “normal” small intestine function looks like.

Wahid has long worked with endoscopy capsule technology for humans and has even patented algorithms and data compression technology for their improved performance. The “camera pills” have been in use for human medicine for some time, he explained, but have yet to be applied in equine health. “We thought, ‘why not try it for veterinary medicine?'” Wahid said. On March 1, they did just that, administering the capsule through a stomach tube directly to the horse’s stomach. For the next eight hours, the capsule and its camera made its way through the horse’s small intestine, offering a continuous picture of what was going on inside.

The team plans to run more tests in the next few months on different horses to gather more data. With this in hand, they plan to pursue funding to further develop equine capsule endoscopy.

“From the engineering side, we can now look at good data,” Wahid explained. “Once we know more about the requirements, we can make it really customizable, a pill specific to the horse.”

https://www.sciencedaily.com/   Science Daily

https://www.sciencedaily.com/releases/2016/03/160316140549.htm  Original web page at Science Daily

Categories
News

New imaging method makes gall bladder removals, other procedures more safe

UCLA researchers have discovered an optimal way to image the bile ducts during gallbladder removal surgeries using a tested and safe dye and a real-time near-infrared florescence laparoscopic camera, a finding that will make the procedure much safer for the hundreds of thousands of people who undergo the procedure each year.

The new imaging procedure can also be used any time surgeons look laparoscopically at the liver and surrounding anatomy.

The gallbladder and liver can be hard to access and visualize when the areas around them are inflamed or surrounded by fat. Using the conventional imaging technique, in which the bile ducts are not as clearly delineated, injuries to the ducts can occur. Those injuries sometimes remain undetected during the surgery, which can lead to serious problems for the patients, said study first author Dr. Ali Zarrinpar, an assistant professor of surgery in the Division of Liver and Pancreas Transplantation.

“Removal of the gallbladder is one of the most commonly performed operations in the United States, with more than 100,000 surgeries performed each year. Injuries to the bile ducts, which carry bile from the liver to the intestines, are rare. But when they do occur, the outcomes can be quite serious and cause life-long consequences,” Zarrinpar said. “Gallbladder removals are one of the most litigated cases in general surgery because of these injuries. Any technique that can reduce the rate of bile duct injury and increase the safety of the operation is good for patients and for surgeons.”

The study appears March 10, 2016 in the early online edition of the peer-reviewed journal Surgical Innovations.

The dye, called indocyanine green (ICG), is approved by the U.S. Food and Drug Administration and has been in use medically for 60 years. The near-infrared florescence laparoscopic camera also is approved for use in colorectal surgeries. This is the first study to optimize the timing and dosing of the dye using his device, Zarrinpar said.

After being injected into a vein, ICG is taken up by the liver and excreted into the bile. The laparoscopic device then detects the fluorescence of the dye in the bile ducts and superimposes that image onto the conventional white light image that surgeons use routinely. This augmented image improves the surgeons’ visualization of the bile ducts, making it easier for them to identify the appropriate anatomy.

Prior to this study, it was unclear just how long before the procedure the dye had to be injected and exactly how much for optimal imaging. Timing, and dosage, often varied widely among practioners. Sometimes, patients got the ICG injected the day prior to their surgery, requiring an extra doctor visit.

However, Zarrinpar and his team found that the dye could be injected as little as 25 to 30 minutes before with good result, although one to four hours prior did improve the image. They also found that patients could receive much less of the dye than many were getting, allowing them to clear the substance in the bile from their bodies much more quickly.

The finding also could lead to a reduction in the number of “open” gallbladder removals and partial liver resections. When the surgeons have trouble visualizing the bile duct and surrounding anatomy, they often will switch from laparoscopic to open surgeries, which make it easier to avoid injuring the bile duct but result in a more difficult and lengthy recovery time for patients.

The prospective UCLA study, which took six months, was small, with 37 patients enrolled. Going forward, Zarrinpar is working to put together a much larger clinical trial to confirm his findings and see if the imaging process and the resulting benefits are cost effective, Zarrinpar said.

“This study provides guidance on the timing and dosing of indocyanine green with respect to anticipated visualization of the biliary tree,” the study states. “NIRFC is practical and effective in delineating extrahepatic biliary anatomy during laparoscopic biliary and hepatic operations, and its use should therefore be considered over traditional methods.”

https://www.sciencedaily.com/releases/  Science Daily

https://www.sciencedaily.com/releases/2016/03/160310164857.htm  Original web page at Science Daily

Categories
News

Personalized heart models for surgical planning

System can convert MRI scans into 3-D-printed, physical models in a few hours. Researchers at MIT and Boston Children’s Hospital have developed a system that can take MRI scans of a patient’s heart and, in a matter of hours, convert them into a tangible, physical model that surgeons can use to plan surgery.

The models could provide a more intuitive way for surgeons to assess and prepare for the anatomical idiosyncrasies of individual patients. “Our collaborators are convinced that this will make a difference,” says Polina Golland, a professor of electrical engineering and computer science at MIT, who led the project. “The phrase I heard is that ‘surgeons see with their hands,’ that the perception is in the touch.”

This fall, seven cardiac surgeons at Boston Children’s Hospital will participate in a study intended to evaluate the models’ usefulness. Golland and her colleagues will describe their new system at the International Conference on Medical Image Computing and Computer Assisted Intervention in October. Danielle Pace, an MIT graduate student in electrical engineering and computer science, is first author on the paper and spearheaded the development of the software that analyzes the MRI scans. Medhi Moghari, a physicist at Boston Children’s Hospital, developed new procedures that increase the precision of MRI scans tenfold, and Andrew Powell, a cardiologist at the hospital, leads the project’s clinical work.

MRI data consist of a series of cross sections of a three-dimensional object. Like a black-and-white photograph, each cross section has regions of dark and light, and the boundaries between those regions may indicate the edges of anatomical structures. Then again, they may not.

Determining the boundaries between distinct objects in an image is one of the central problems in computer vision, known as “image segmentation.” But general-purpose image-segmentation algorithms aren’t reliable enough to produce the very precise models that surgical planning requires.

Typically, the way to make an image-segmentation algorithm more precise is to augment it with a generic model of the object to be segmented. Human hearts, for instance, have chambers and blood vessels that are usually in roughly the same places relative to each other. That anatomical consistency could give a segmentation algorithm a way to weed out improbable conclusions about object boundaries.

The problem with that approach is that many of the cardiac patients at Boston Children’s Hospital require surgery precisely because the anatomy of their hearts is irregular. Inferences from a generic model could obscure the very features that matter most to the surgeon.

In the past, researchers have produced printable models of the heart by manually indicating boundaries in MRI scans. But with the 200 or so cross sections in one of Moghari’s high-precision scans, that process can take eight to 10 hours.

“They want to bring the kids in for scanning and spend probably a day or two doing planning of how exactly they’re going to operate,” Golland says. “If it takes another day just to process the images, it becomes unwieldy.

Pace and Golland’s solution was to ask a human expert to identify boundaries in a few of the cross sections and allow algorithms to take over from there. Their strongest results came when they asked the expert to segment only a small patch –one-ninth of the total area — of each cross section.

In that case, segmenting just 14 patches and letting the algorithm infer the rest yielded 90 percent agreement with expert segmentation of the entire collection of 200 cross sections. Human segmentation of just three patches yielded 80 percent agreement.

“I think that if somebody told me that I could segment the whole heart from eight slices out of 200, I would not have believed them,” Golland says. “It was a surprise to us.” Together, human segmentation of sample patches and the algorithmic generation of a digital, 3-D heart model takes about an hour. The 3-D-printing process takes a couple of hours more.

Currently, the algorithm examines patches of unsegmented cross sections and looks for similar features in the nearest segmented cross sections. But Golland believes that its performance might be improved if it also examined patches that ran obliquely across several cross sections. This and other variations on the algorithm are the subject of ongoing research.

The clinical study in the fall will involve MRIs from 10 patients who have already received treatment at Boston Children’s Hospital. Each of seven surgeons will be given data on all 10 patients — some, probably, more than once. That data will include the raw MRI scans and, on a randomized basis, either a physical model or a computerized 3-D model, based, again at random, on either human segmentations or algorithmic segmentations.

Using that data, the surgeons will draw up surgical plans, which will be compared with documentation of the interventions that were performed on each of the patients. The hope is that the study will shed light on whether 3-D-printed physical models can actually improve surgical outcomes.

http://www.sciencedaily.com/  Science Daily

http://www.sciencedaily.com/releases/2015/09/150917130030.htm  Original web page at Science Daily

Categories
News

Scientists visualize critical part of basal ganglia pathways

Certain diseases, like Parkinson’s and Huntingdon’s disease, are associated with damage to the pathways between the brain’s basal ganglia regions. The basal ganglia sits at the base of the brain and is responsible for, among other things, coordinating movement. It is made up of four interconnected, deep brain structures that imaging techniques have previously been unable to visualize.

For the first time, Carnegie Mellon University BrainHub scientists have used a non-invasive brain-imaging tool to detect the pathways that connect the parts of the basal ganglia. Published in NeuroImage, the research provides a better understanding of this area’s circuitry, which could potentially lead to technologies to help track disease progression for Parkinson’s and Huntington’s disease and other neurological disorders.

“Clinically, it is difficult to see the pathways within the basal ganglia with neuroimaging techniques, like the ever popular MRI, because many of the fiber bundles that make up key parts of this circuit are very small and buried within dense cell bodies,” said Patrick Beukema, the lead author and a graduate student in the Center for Neuroscience at the University of Pittsburgh (CNUP) and the joint Pitt and CMU Center for the Basis of Neural Cognition (CNBC).

“For reasons that are not fully understood, the pathways that connect the basal ganglia’s regions are highly susceptible to damage. Because they are important for motor control, this damage can result in substantial motor deficits, so it is highly desirable to discover more about this area,” Beukema said.

Diffusion MRI measures the movement of water molecules to create a visual representation of the brain’s axons. In this study, the research team used two types of diffusion imaging to visualize the major pathways that connect the internal circuitry of the basal ganglia. Sixty healthy adults had their brains scanned using diffusion spectrum imaging, which provided a picture of the orientation of moving water molecules. And, multi-shell imaging was used on 78 healthy adults to get similar images using different imaging parameters.

The results from both imaging techniques showed that it is possible to detect the small but important fiber connections in the brain. The researchers also found that by looking at the general patterns of water movement in the basal ganglia, they could automatically distinguish one small brain region from the other.

“The pathways that Patrick has been able to visualize are critical to so many functions, yet we haven’t been able to see them in the living human brain before. This opens the door to so many research and clinical opportunities,” said Timothy J. Verstynen, assistant professor of psychology in CMU’s Dietrich College of Humanities and Social Sciences and CNBC faculty member.

This is not the first brain research breakthrough to happen at Carnegie Mellon. CMU is the birthplace of artificial intelligence and cognitive psychology and has been a leader in the study of brain and behavior for more than 50 years. The university has created some of the first cognitive tutors, helped to develop the Jeopardy-winning Watson, founded a groundbreaking doctoral program in neural computation, and completed cutting-edge work in understanding the genetics of autism. Building on its strengths in biology, computer science, psychology, statistics and engineering, CMU launched BrainHub, an initiative that focuses on how the structure and activity of the brain give rise to complex behaviors.

http://www.sciencedaily.com/ Science Daily

http://www.sciencedaily.com/releases/2015/08/150817132333.htm  Original web page at Science Daily

Categories
News

‘Memory region’ of brain also involved in conflict resolution

The hippocampus in the brain’s temporal lobe is responsible for more than just long-term memory. Researchers have for the first time demonstrated that it is also involved in quick and successful conflict resolution. The team headed by Prof Dr Nikolai Axmacher from the Ruhr-Universität Bochum (RUB), together with colleagues from the University Hospital of Bonn as well as in Aachen and Birmingham, reported in the journal Current Biology.

In their everyday life, people are constantly confronted with decision conflicts, especially if they need to suppress an action that would have made sense under normal circumstances. For example: when the pedestrian lights go green, a pedestrian would normally start walking. If, however, a car comes speeding along at the same time, the pedestrian should stay where he is. In their experiment, researchers opted for a less threatening situation. Test participants heard the words “high” or “low” spoken in a high or low tone, and they had to state — regardless of the meaning of the word — at what pitch the speaker said them. If the pitch doesn’t correspond with the meaning of the word, a conflict is generated: the participants would answer more slowly and make more mistakes.

The team demonstrated with two different measurement methods that the hippocampus is active in such conflicting situations; this applies particularly when a person solves the conflicts quickly and successfully. Nikolai Axmacher from the Institute of Cognitive Neuroscience and his colleagues analysed the brain activity in healthy participants with functional magnetic resonance imaging. They gained the same results in epilepsy patients who had EEG electrodes implanted in the hippocampus for the purpose of surgery planning; this is how the researchers could measure the activity in that brain region directly.

Because the hippocampus is essential for memory, the researchers speculate about its role in conflict resolution: “Our data show first of all a completely new function of the Hippocampus — processing of activity conflicts,” says Carina Oehrn from the Department of Epileptology at the University Hospital of Bonn. “However, in order to answer the question how that function interacts with memory processes, we will have to carry out additional tests.” “Perhaps the memory system becomes particularly active if a conflict has been successfully resolved,” speculates Nikolai Axmacher. “Permanently unsolved conflicts can’t be used for learning helpful lessons for the future. According to our model, the brain works like a filter. It responds strongly to resolved conflicts, but not to unsolved conflicts or standard situations. However, we have to verify this hypothesis in additional studies.”

http://www.sciencedaily.com/  Science Daily

http://www.sciencedaily.com/releases/2015/08/150820134704.htm  Original web page at Science Daily

Categories
News

Scientists visualize critical part of basal ganglia pathways

Certain diseases, like Parkinson’s and Huntingdon’s disease, are associated with damage to the pathways between the brain’s basal ganglia regions. The basal ganglia sits at the base of the brain and is responsible for, among other things, coordinating movement. It is made up of four interconnected, deep brain structures that imaging techniques have previously been unable to visualize.

For the first time, Carnegie Mellon University BrainHub scientists have used a non-invasive brain-imaging tool to detect the pathways that connect the parts of the basal ganglia. Published in NeuroImage, the research provides a better understanding of this area’s circuitry, which could potentially lead to technologies to help track disease progression for Parkinson’s and Huntington’s disease and other neurological disorders.

“Clinically, it is difficult to see the pathways within the basal ganglia with neuroimaging techniques, like the ever popular MRI, because many of the fiber bundles that make up key parts of this circuit are very small and buried within dense cell bodies,” said Patrick Beukema, the lead author and a graduate student in the Center for Neuroscience at the University of Pittsburgh (CNUP) and the joint Pitt and CMU Center for the Basis of Neural Cognition (CNBC).

“For reasons that are not fully understood, the pathways that connect the basal ganglia’s regions are highly susceptible to damage. Because they are important for motor control, this damage can result in substantial motor deficits, so it is highly desirable to discover more about this area,” Beukema said.

Diffusion MRI measures the movement of water molecules to create a visual representation of the brain’s axons. In this study, the research team used two types of diffusion imaging to visualize the major pathways that connect the internal circuitry of the basal ganglia. Sixty healthy adults had their brains scanned using diffusion spectrum imaging, which provided a picture of the orientation of moving water molecules. And, multi-shell imaging was used on 78 healthy adults to get similar images using different imaging parameters.

The results from both imaging techniques showed that it is possible to detect the small but important fiber connections in the brain. The researchers also found that by looking at the general patterns of water movement in the basal ganglia, they could automatically distinguish one small brain region from the other.

“The pathways that Patrick has been able to visualize are critical to so many functions, yet we haven’t been able to see them in the living human brain before. This opens the door to so many research and clinical opportunities,” said Timothy J. Verstynen, assistant professor of psychology in CMU’s Dietrich College of Humanities and Social Sciences and CNBC faculty member.

This is not the first brain research breakthrough to happen at Carnegie Mellon. CMU is the birthplace of artificial intelligence and cognitive psychology and has been a leader in the study of brain and behavior for more than 50 years. The university has created some of the first cognitive tutors, helped to develop the Jeopardy-winning Watson, founded a groundbreaking doctoral program in neural computation, and completed cutting-edge work in understanding the genetics of autism. Building on its strengths in biology, computer science, psychology, statistics and engineering, CMU launched BrainHub, an initiative that focuses on how the structure and activity of the brain give rise to complex behaviors.

http://www.sciencedaily.com/  Science Daily

http://www.sciencedaily.com/releases/2015/08/150817132333.htm  Original web page at Scie

Categories
News

* DNA damage seen in patients undergoing CT scanning, study finds

Using new laboratory technology, scientists have shown that cellular damage is detectable in patients after CT scanning, according to a new study led by researchers at the Stanford University School of Medicine.

“We now know that even exposure to small amounts of radiation from computed tomagraphy scanning is associated with cellular damage,” said Patricia Nguyen, MD, one of the lead authors of the study and an assistant professor of cardiovascular medicine at Stanford. “Whether or not this causes cancer or any negative effect to the patient is still not clear, but these results should encourage physicians toward adhering to dose reduction strategies.”

The study will be published online July 22 in the Journal of the American College of Cardiology: Cardiovascular Imaging. Won Hee Lee, PhD, and Yong Fuga Li, PhD, both postdoctoral scholars, are the study’s other lead authors. “The use of medical imaging for heart disease has exploded in the past decade,” said Joseph Wu, MD, senior author of the study. Wu is a professor of medicine and of radiology and the director of the Stanford Cardiovascular Institute. “These tests expose patients to a nontrivial amount of low-dose radiation. But nobody really knows exactly what this low-dose radiation does to the patient. We now have the technology that allows us to look at very subtle, cell-level changes.”

Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer. The worry is that increased radiation exposure from such diagnostic procedures as CT scans, which expose the body to low-dose X-ray beams, can damage DNA and create mutations that spur cells to grow into tumors.

But there has been limited scientific evidence to date that shows the effects of this low-dose radiation on the body, according to the study. Currently, there is a bill winding its way through Congress to fund more research on the health effects of low doses of radiation, Wu said. This study’s findings point to the need for more research, he said.

“I think there are legitimate concerns about the exposure to low-dose radiation, but the problem is that it is difficult to prove a causal relationship with cancer,” Nguyen said. “Even though we show some damage is occurring at a cellular level, this damage is being repaired. It is the damage that escapes repair, or the cells that are not eliminated and are mutated, that go on and produce cancer. We can’t track those cells with current technology.”

In this study, researchers examined the effects on human cells of low-dose radiation from a wide range of cardiac and vascular CT scans. These imaging procedures are commonly used for a number of reasons, including management of patients suspected of having obstructive coronary artery disease, and for those with aortic stenosis, in preparation of transcatheter aortic valve replacement.

A CT scan, which is used for imaging and diagnostic procedures throughout the body, exposes patients to at least 150 times the amount of radiation from a single chest X-ray, the study said. In 2007, the National Cancer Institute estimated that 29,000 future cancer cases could be attributed to the 72 million CT scans performed in the country that year. But the reliability of such predictions depends on how scientists measure the underlying link between radiation and cancer in the first place, Nguyen said.

“Because we don’t know much about the effects of low-dose radiation — all we know is about high doses from atomic bomb blast survivors — we just assume it’s directly proportional to the dose,” said Nguyen. “We wanted to see what really happens at the cellular level.”

Researchers examined the blood of 67 patients undergoing cardiac CT angiograms. Using such techniques as whole-genome sequencing and flow cytometry to measure biomarkers of DNA damage, researchers examined the blood of patients both before and after undergoing the procedure.

Results showed an increase in DNA damage and cell death, as well as increased expression of genes involved in cell repair and death, the study said. Although most cells damaged by the scan were repaired, a small percentage of the cells died, the study said.

“These findings raise the possibility that radiation exposure from cardiac CT angiography may cause DNA damage that can lead to mutations if damaged cells are not repaired or eliminated properly,” the study said. “Cumulative cell death after repeated exposures may also be problematic.”

“We need to learn more because it’s not a benign effect even at these low dosages,” Nguyen said. “Our research supports the idea that maybe physicians shouldn’t just use the best image quality in all cases. We shouldn’t eliminate CT scans because they’re obviously important, but you can make it safer by reducing the doses, by getting better machines and technology, and by giving patients something to protect them.”

Nguyen added: “It is important to note that we did not detect any DNA damage in patients receiving the lowest doses of radiation and who were of average weight and had regular heart rates.”

http://www.sciencedaily.com/ Science Daily

http://www.sciencedaily.com/releases/2015/07/150722144634.htm Original web page at Science Daily

Categories
News

Brain imaging may help predict future behavior

Noninvasive brain scans, such as functional magnetic resonance imaging, have led to basic science discoveries about the human brain, but they’ve had only limited impacts on people’s day-to-day lives. A review article published in the January 7 issue of the Cell Press journal Neuron, however, highlights a number of recent studies showing that brain imaging can help predict an individual’s future learning, criminality, health-related behaviors, and response to drug or behavioral treatments. The technology may offer opportunities to personalize educational and clinical practices. Dr. John Gabrieli of the Massachusetts Institute of Technology in Cambridge and his colleagues describe the predictive power of brain imaging across a variety of different future behaviors, including infants’ later performance in reading, students’ later performance in math, criminals’ likelihood of becoming repeat offenders, adolescents’ future drug and alcohol use, and addicts’ likelihood of relapse. “Presently, we often wait for failure, in school or in mental health, to prompt attempts to help, but by then a lot of harm has occurred,” says Dr. Gabrieli. “If we can use neuroimaging to identify individuals at high risk for future failure, we may be able to help those individuals avoid such failure altogether.” The authors also point to the clear ethical and societal issues that are raised by studies attempting to predict individuals’ behavior. “We will need to make sure that knowledge of future behavior is used to personalize educational and medical practices, and not be used to limit support for individuals at higher risk of failure,” says Dr. Gabrieli. “For example, rather than simply identifying individuals to be more or less likely to succeed in a program of education, such information could be used to promote differentiated education for those less likely to succeed with the standard education program.”

http://www.sciencedaily.com/  Science Daily

http://www.sciencedaily.com/releases/2015/01/150107122904.htm Original web page at Science Daily

Categories
News

New non-invasive method can detect Alzheimer’s disease early

No methods currently exist for the early detection of Alzheimer’s disease, which affects one out of nine people over the age of 65. Now, an interdisciplinary team of Northwestern University scientists and engineers has developed a noninvasive MRI approach that can detect the disease in a living animal. And it can do so at the earliest stages of the disease, well before typical Alzheimer’s symptoms appear. Led by neuroscientist William L. Klein and materials scientist Vinayak P. Dravid, the research team developed an MRI (magnetic resonance imaging) probe that pairs a magnetic nanostructure (MNS) with an antibody that seeks out the amyloid beta brain toxins responsible for onset of the disease. The accumulated toxins, because of the associated magnetic nanostructures, show up as dark areas in MRI scans of the brain. This ability to detect the molecular toxins may one day enable scientists to both spot trouble early and better design drugs or therapies to combat and monitor the disease. And, while not the focus of the study, early evidence suggests the MRI probe improves memory, too, by binding to the toxins to render them “handcuffed” to do further damage. “We have a new brain imaging method that can detect the toxin that leads to Alzheimer’s disease,” said Klein, who first identified the amyloid beta oligomer in 1998. He is a professor of neurobiology in the Weinberg College of Arts and Sciences. “Using MRI, we can see the toxins attached to neurons in the brain,” Klein said. “We expect to use this tool to detect this disease early and to help identify drugs that can effectively eliminate the toxin and improve health.” With the successful demonstration of the MRI probe, Northwestern researchers now have established the molecular basis for the cause, detection by non-invasive MR imaging and treatment of Alzheimer’s disease. Dravid introduced this magnetic nanostructure MRI contrast enhancement approach for Alzheimer’s following his earlier work utilizing MNS as smart nanotechnology carriers for targeted cancer diagnostics and therapy. (A MNS is typically 10 to 15 nanometers in diameter; one nanometer is one billionth of a meter.) Details of the new Alzheimer’s disease diagnostic are published by the journal Nature Nanotechnology. Klein and Dravid are co-corresponding authors. The emotional and economic impacts of Alzheimer’s disease are devastating. This year, the direct cost of the disease in the United States is more than $200 billion, according to the Alzheimer’s Association’s “2014 Alzheimer’s Disease Facts and Figures.” By the year 2050, that cost is expected to be $1.1 trillion as baby boomers age. And these figures do not account for the lost time of caregivers. This new MRI probe technology is detecting something different from conventional technology: toxic amyloid beta oligomers instead of plaques, which occur at a stage of Alzheimer’s when therapeutic intervention would be very late. Amyloid beta oligomers now are widely believed to be the culprit in the onset of Alzheimer’s disease and subsequent memory loss. In a diseased brain, the mobile amyloid beta oligomers attack the synapses of neurons, destroying memory and ultimately resulting in neuron death. As time progresses, the amyloid beta builds up and starts to stick together, forming the amyloid plaques that current probes target. Oligomers may appear more than a decade before plaques are detected. “Non-invasive imaging by MRI of amyloid beta oligomers is a giant step forward towards diagnosis of this debilitating disease in its earliest form,” said Dravid, the Abraham Harris Professor of Materials Science and Engineering at the McCormick School of Engineering and Applied Science.

There is a major need for what the Northwestern research team is doing — identifying and detecting the correct biomarker for new drug discovery. Despite extraordinary efforts, no effective drugs exist yet for Alzheimer’s disease. This MRI method could be used to determine how well a new drug is working,” Dravid said. “If a drug is effective, you would expect the amyloid beta signal to go down.” The nontoxic MRI probe was delivered intranasally to mouse models with Alzheimer’s disease and control animals without the disease. In animals with Alzheimer’s, the toxins’ presence can be seen clearly in the hippocampus in MRI scans of the brain. No dark areas, however, were seen in the hippocampus of the control group. The ability to detect amyloid beta oligomers, Klein said, is important for two reasons: amyloid beta oligomers are the toxins that damage neurons, and the oligomers are the first sign of trouble in the disease process, appearing before any other pathology. Klein, Dravid and their colleagues also observed that the behavior of animals with Alzheimer’s improved even after receiving a single dose of the MRI probe. “While preliminary, the data suggests the probe could be used not only as a diagnostic tool but also as a therapeutic,” said Kirsten L. Viola, a co-first author of the study and a research manager in Klein’s laboratory. Along with the studies in live animals, the research team also studied human brain tissue from Northwestern’s Cognitive Neurology and Alzheimer’s Disease Center. The samples were from individuals who died from Alzheimer’s and those who did not have the disease. After introducing the MRI probe, the researchers saw large dark areas in the Alzheimer brains, indicating the presence of amyloid beta oligomers. The title of the paper is “Towards non-invasive diagnostic imaging of early-stage Alzheimer’s disease.”

http://www.sciencedaily.com/  Science Daily

http://www.sciencedaily.com/releases/2014/12/141222143019.htm  Original web page at Science Daily

Categories
News

MRI-guided biopsy for brain cancer improves diagnosis

“There are many different types of brain cancer. Making an accurate diagnosis is paramount because the diagnosis dictates the subsequent course of treatment,” said Clark C. Chen, MD, PhD, vice-chairman of research, division of neurosurgery, UC San Diego School of Medicine. “For instance, the treatment of glioblastoma is fundamentally different than the treatment for oligodendroglioma, another type of brain tumor.”  Chen said that as many as one third of brain tumor biopsies performed in the traditional manner can result in misdiagnosis. He cited two challenges with conventional biopsy. “First, because distinct areas of brain tumors exhibit different cell densities and higher cell densities are generally associated with higher tumor grade, biopsies taken from one region may yield a different diagnosis than if another area is biopsied,” said Chen. “Second, because tumors are hidden within the brain, surgeons must use mathematical algorithms to target where the biopsy should occur. As with all calculations, the process is subject to errors that the surgeon cannot easily correct in real time once the biopsy has begun.” Chen’s team applied an MRI technique called Restriction Spectrum Imaging (RSI) to visualize the parts of the brain tumor that contain different cell densities. “RSI allows us to identify the regions of the cell that are most representative of the entire tumor,” said Chen. “By targeting biopsies to these areas, we minimize the number of biopsies needed but still achieve a sampling that best characterizes the entire tumor.” To ensure a targeted biopsy, Chen performs the procedure in the MRI suite while the patient is under general anesthesia. Because conventional biopsy equipment cannot be used in the MRI, Chen uses a special MRI-compatible system called ClearPoint®. This system utilizes an integrated set of hardware, software, and surgical equipment to allow the surgeon to target and visualize the path of the biopsy as well as the actual biopsy site, intraoperatively. “Surgeons have been performing brain biopsies in a near blind manner for the past fifty years. The ability to see where the biopsy needle is located and where the biopsy is being performed in real time is groundbreaking,” said Chen. “This combination of technologies gives me an opportunity to immediately adjust my surgical approach while minimizing risk.”

http://www.sciencedaily.com/  Science Daily

May 27, 2014

http://www.sciencedaily.com/releases/2014/04/140430142822.htm  Original web page at Science Daily

 

Categories
News

MRI reveals genetic activity: Deciphering genes’ roles in learning and memory

Doctors commonly use magnetic resonance imaging (MRI) to diagnose tumors, damage from stroke, and many other medical conditions. Neuroscientists also rely on it as a research tool for identifying parts of the brain that carry out different cognitive functions. Now, a team of biological engineers at MIT is trying to adapt MRI to a much smaller scale, allowing researchers to visualize gene activity inside the brains of living animals. Tracking these genes with MRI would enable scientists to learn more about how the genes control processes such as forming memories and learning new skills, says Alan Jasanoff, an MIT associate professor of biological engineering and leader of the research team. “The dream of molecular imaging is to provide information about the biology of intact organisms, at the molecule level,” says Jasanoff, who is also an associate member of MIT’s McGovern Institute for Brain Research. “The goal is to not have to chop up the brain, but instead to actually see things that are happening inside.” To help reach that goal, Jasanoff and colleagues have developed a new way to image a “reporter gene” — an artificial gene that turns on or off to signal events in the body, much like an indicator light on a car’s dashboard. In the new study, the reporter gene encodes an enzyme that interacts with a magnetic contrast agent injected into the brain, making the agent visible with MRI. This approach, described in a recent issue of the journal Chemical Biology, allows researchers to determine when and where that reporter gene is turned on. MRI uses magnetic fields and radio waves that interact with protons in the body to produce detailed images of the body’s interior. In brain studies, neuroscientists commonly use functional MRI to measure blood flow, which reveals which parts of the brain are active during a particular task. When scanning other organs, doctors sometimes use magnetic “contrast agents” to boost the visibility of certain tissues.

The new MIT approach includes a contrast agent called a manganese porphyrin and the new reporter gene, which codes for a genetically engineered enzyme that alters the electric charge on the contrast agent. Jasanoff and colleagues designed the contrast agent so that it is soluble in water and readily eliminated from the body, making it difficult to detect by MRI. However, when the engineered enzyme, known as SEAP, slices phosphate molecules from the manganese porphyrin, the contrast agent becomes insoluble and starts to accumulate in brain tissues, allowing it to be seen. The natural version of SEAP is found in the placenta, but not in other tissues. By injecting a virus carrying the SEAP gene into the brain cells of mice, the researchers were able to incorporate the gene into the cells’ own genome. Brain cells then started producing the SEAP protein, which is secreted from the cells and can be anchored to their outer surfaces. That’s important, Jasanoff says, because it means that the contrast agent doesn’t have to penetrate the cells to interact with the enzyme. Researchers can then find out where SEAP is active by injecting the MRI contrast agent, which spreads throughout the brain but accumulates only near cells producing the SEAP protein. In this study, which was designed to test this general approach, the detection system revealed only whether the SEAP gene had been successfully incorporated into brain cells. However, in future studies, the researchers intend to engineer the SEAP gene so it is only active when a particular gene of interest is turned on. Jasanoff first plans to link the SEAP gene with so-called “early immediate genes,” which are necessary for brain plasticity — the weakening and strengthening of connections between neurons, which is essential to learning and memory. “As people who are interested in brain function, the top questions we want to address are about how brain function changes patterns of gene expression in the brain,” Jasanoff says. “We also imagine a future where we might turn the reporter enzyme on and off when it binds to neurotransmitters, so we can detect changes in neurotransmitter levels as well.” Assaf Gilad, an assistant professor of radiology at Johns Hopkins University, says the MIT team has taken a “very creative approach” to developing noninvasive, real-time imaging of gene activity. “These kinds of genetically engineered reporters have the potential to revolutionize our understanding of many biological processes,” says Gilad, who was not involved in the study.

http://www.sciencedaily.com/  Science Daily

April 15, 2014

http://www.sciencedaily.com/releases/2014/03/140325113300.htm  Original web page at Science Daily

Categories
News

Preoperative PET cuts unnecessary lung surgeries in half

New quantitative data suggests that 30 percent of the surgeries performed for non-small cell lung cancer patients in a community-wide clinical study were deemed unnecessary. Additionally, positron emission tomography (PET) was found to reduce unnecessary surgeries by 50 percent, according to research published in the March issue of the Journal of Nuclear Medicine. PET imaging prior to surgery helps stage a patient’s disease by providing functional images of tumors throughout the body, especially areas where cancer has spread, otherwise known as metastasis. Few studies have been able to pin down exactly what impact preoperative PET has on clinical decision-making and resulting treatment. Preliminary review of the data from this long-term, observational study of an entire community of veterans was inconclusive about the utility of PET, but after a more thorough statistical analysis accounting for selection bias and other confounding factors, the researchers were able to conclude that PET imaging eliminated approximately half of unnecessary surgeries. “It has become standard of care for lung cancer patients to receive preoperative PET imaging,” said Steven Zeliadt, PhD, lead author of the study conducted at VA Puget Sound Health Care System and associate professor for the University of Washington in Seattle, Wash. “The prevailing evidence reinforces the general understanding within the medical community that PET is very useful for identifying occult metastasis and that it helps get the right people to surgery while avoiding unnecessary surgeries for those who would not benefit.”

For this study, researchers reviewed newly diagnosed non-small lung cancer patients who received preoperative PET to assess the real-life effectiveness of PET as a preventative measure against unnecessarily invasive treatment across a community of patients. A total of 2,977 veterans who underwent PET during disease staging from 1997 to 2009 were included in the study. Of these, 976 patients underwent surgery to resect their lung cancer. During surgery or within 12 months of surgery, 30 percent of these patients were found to have advanced-stage metastatic disease, indicating an unnecessary surgery. Interestingly, the use of PET increased during the study period from 9% to 91%. Conventional multivariate analyses was followed by instrumental variable analyses to account for unobserved anomalies, such as when patients did not undergo PET when it would have been clinically recommended to do so. This new data has the potential to change policy and recommendations regarding the use of oncologic PET for more accurate tumor staging. “We will likely build more quality measures around this research so that preoperative PET is more strongly recommended to improve the management of care for these patients,” added Zeliadt.

http://www.sciencedaily.com/ Science Daily

April 15, 2014

http://www.sciencedaily.com/releases/2014/03/140326142309.htm  Original web page at Science Daily

Categories
News

MRI to ‘see through’ metal screws developed to follow patients after hip fracture surgery

People who sustain the most common type of hip fracture, known as a femoral neck fracture, are at increased risk of complications. A special type of MRI developed at Hospital for Special Surgery in collaboration with GE Healthcare can show a detailed image following fracture repair, without the distortion caused by metal surgical screws that are problematic in standard MRIs. Each year, more than 340,000 people suffer a broken hip in the United   States. The femoral neck, the area just below the ball of the hip’s ball-and-socket joint, is the most common site of fracture, accounting for 45 to 53 percent of cases. People with this type of injury are at high risk of complications because the blood supply to the fractured portion of the bone is often disrupted. The concern is that the decreased blood supply will lead to non-healing or the death of bone cells, known as osteonecrosis. Researchers at Hospital for Special Surgery developed a specially sequenced, contrast-enhanced MRI to identify potential problems so doctors can intervene early and prevent further damage to the joint. “This new MRI greatly improves the visualization of bone and soft tissue when there is metal in a joint, such as the screws used to repair a hip fracture,” explained Hollis G. Potter, M.D., Chairman of the Department of Radiology and Imaging at HSS. A study on this subject, titled “Femoral Head Osteonecrosis Following Anatomic Stable Fixation of Femoral Neck Fractures: An in-vivo MRI Study” will be presented at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) in New Orleans on March 11, 2014. The Department of Radiology and Imaging at HSS is known internationally as a premier center for world class musculoskeletal clinical and research imaging. “Imaging is a vital component of the integrated care system provided by HSS,” said Dr. Potter. “Our team is constantly optimizing the ability to image the earliest signs of a musculoskeletal condition, disease progression and/or healing.”

Despite advances in surgical hardware and techniques, femoral neck fractures remain a significant clinical challenge. The primary complications arising from femoral neck fractures are non-union and osteonecrosis, which occurs when the blood supply to the bone is disrupted. This causes bone cells to die, which can destroy the joint and lead to arthritis. With respect to femoral neck hip fractures, this is the first MRI that can “see through” surgical screws to detect early signs of osteonecrosis, so that interventions can be initiated before there is further damage, such as collapse of the bone or osteoarthritis. In the study, patients had an MRI known as a “multi-acquisition variable-resonance image combination,” or MAVRIC MRI, three months and 12 months after surgery. “The MAVRIC MRI provided us with information that could not be ascertained from x-rays or a standard MRI,” Dr. Potter explained. “A special 3-D fast spin echo technique minimized distortion caused by metal screws used to repair the fracture, facilitating assessment of the hip joint and any potential problems concerning osteonecrosis or non-union.” MRI revealed decreased blood flow to the injured area and osteonecrosis in 80 percent of patients in the superomedial quadrant of the femoral head. However, despite these findings, patients demonstrated excellent radiographic and functional outcomes. Researchers attributed this to a surgical technique that entailed stabilizing the broken bones with screws and restoring the fracture to the correct alignment and normal anatomical position.

http://www.sciencedaily.com/ Science Daily

April 1, 2014

http://www.sciencedaily.com/releases/2014/03/140311133625.htm Original web page at Science Daily

Categories
News

New imaging technique can diagnose common heart condition

A new imaging technique for measuring blood flow in the heart and vessels can diagnose a common congenital heart abnormality, bicuspid aortic valve, and may lead to better prediction of complications. A Northwestern Medicine team reported the finding in the journal Circulation. In the study, the authors demonstrated for the first time a previously unknown relationship between heart valve abnormalities, blood flow changes in the heart and aortic disease. They showed that blood flow changes were driven by specific types of abnormal aortic valves, and they were able to directly associate blood flow patterns with aortic diseases. “Blood flow in patients with bicuspid aortic valves was significantly different compared to that in patients with normal valves,” said senior author Michael Markl, associate professor of radiology at Northwestern University Feinberg School of Medicine. “We now have direct evidence that bicuspid valves induce changes in blood flow and that the type of flow abnormality may contribute to the development of different expressions of heart disease in these patients.” Bicuspid aortic valve is a heart condition in which the aortic valve only has two leaflets, instead of the normal three. It affects approximately one to two of every 100 Americans and is the most common congenital cardiovascular abnormality. Despite the absence of symptoms, the condition can lead to significant and potentially life-threatening complications, including enlargement of the blood vessel (aneurysm) and rupture. However, it is not known which patients are at the highest risk for complications and whether the condition’s origin is genetic or related to changes in blood flow.

The 4D flow MRI (magnetic resonance imaging) used in the study has the potential for better predictive ability. “The study demonstrated that new imaging techniques may help to determine patient-specific changes in blood flow to better understand which regional areas of the aorta are most prone to developing disease,” Markl said. “In addition, the knowledge of abnormal blood flow patterns could be important to better identify patients at risk for the development of heart disease.” Markl’s team was surprised to see such a clear distinction between individual expressions of aortic complications for different types of congenital valve disease. While the current findings show evidence of this link, long-term observational studies are needed to better understand the potential of 4D flow MRI to improve disease prediction ability. A longitudinal follow-up study in patients with bicuspid aortic valves is currently underway at Northwestern. “Ultimately, we hope that this imaging technique will facilitate early identification of high-risk blood flow patterns associated with progressive aortic enlargement, improving the allocation of health care resources in caring for patients with this prevalent condition,” Markl said.

http://www.sciencedaily.com/ Science Daily March 4, 2014

http://www.sciencedaily.com/releases/2014/02/140211174835.htm  Original web page at Science Daily

Categories
News

Guatemala’s jaguars: Capturing phantoms in photos

The Wildlife Conservation Society (WCS) has released a photograph of a male jaguar taken by a remote camera trap in Guatemala’s Maya Biosphere Reserve. Activated by motion or heat differentials, camera traps “capture” pictures of secretive and elusive animals in the wild. Because each jaguar’s pattern of spots is unique, the photographs can be used to identify individuals and estimate abundance. Integrating experience from more than 80 jaguar surveys, WCS has issued an updated version of its 2004 manual of methods to estimate jaguar population density using camera traps. The new manual — available in Spanish and English at: http://www.wcsguatemala.org/en-us/wildlife/jaguar.aspx– shares lessons learned and recommendations for design and analysis that can improve density estimates. Because jaguars roam widely seeking prey, the manual notes that density estimates require huge sample areas. In keeping with that recommendation, WCS is leading a survey in Guatemala using 50 stations of paired camera traps to cover a 500-square kilometer area of community-managed forest to learn more about these elusive creatures, including how many exist in the region.

“By protecting jaguar populations in globally significant, strategically located strongholds, our program contributes to range wide conservation of this species,” said WCS Jaguar Coordinator Dr. John Polisar. “The jaguar in this photo is secure because its home is defended against illegal encroachments that would clear its forest habitat, and uncontrolled hunting that would reduce its prey. The intent of the new manual is to share the knowledge we have gained, and it provides guidance on design and analysis for a next generation of jaguar population studies that are essential to informing conservation actions.” WCS’s jaguar monitoring advances in Guatemala are being made possible through the generous financial support of: the Liz Claiborne and Art Ortenberg Foundation; the US Agency for International Development/Rainforest Alliance — Climate, Nature, and Communities in Guatemala Program; and the US Department of Interior — International Technical Assistance Program. The Andean Bear Conservation Alliance is enabling this large scale jaguar survey through sharing equipment.

Science Daily
June 11, 2013

Original web page at Science Daily

Categories
News

Seeing the brain’s circuits with a new clarity

For scientists working to uncover the mysteries of the brain, fat is a problem. The fats inside cells bend and scatter light, obscuring researchers’ views when they try to peer deep into tissue. A new technique developed by Howard Hughes Medical Institute (HHMI) scientists solves that problem by removing the fat from the brain and supporting the remaining brain structures in a hydrogel—literally giving scientists a clear view of an intact brain. The technique, called CLARITY, transforms biological tissue into an optically transparent sample that retains its original structure and molecular information. “You can turn a mouse brain into essentially a completely transparent form within four to five days,” says HHMI Early Career Scientists Karl Deisseroth, who led the development of the new technique. The method has the potential to enable a new understanding of the local and global connectivity of circuits in the brain, says Deisseroth, who studies the dynamics of neural circuits in his lab at Stanford University. Deisseroth’s team reports on its ability to use the technique to clarify the intact brain of a mouse, as well as samples of postmortem human brain tissue, on April 10, 2013 in the journal Nature. “You can turn a mouse brain into essentially a completely transparent form within four to five days.”

Tissue transformed by CLARITY is permeable, so specific proteins can be labeled for study. It is also stable enough to withstand treatments that remove labeling molecules so that the same tissue can be reexamined many times. Under the microscope, a mouse brain treated with CLARITY reveals the long-distance connections between neurons in distant parts of the brain, as well as the fine details of each cell’s structure. For clinical samples, CLARITY reveals three-dimensional structures that would be difficult to discern in thinly sectioned tissue. A few years ago, Deisseroth’s lab developed optogenetics, a light-based technology that gives researchers precise control over the activity of specific nerve cells in living mice. “That’s been useful, but it hasn’t allowed us to come to a deeper, circuit-level understanding of how physiology and behavior arise from the neurons that we target,” he says. “That’s because we don’t know in detail how those neurons are connected in the tissue, both locally and globally. We can control cells and see how that affects behavior – but to turn that into a deep understanding of how the circuitry works has been a challenge,” he says. Understanding how the neurons they are studying were connected to others in the brain was difficult with existing technology. To visualize neurons under a light microscope, scientists must slice the tissue into very thin sections, losing the context of surrounding tissue. Reconstructing even a small volume of the original tissue’s three-dimensional structure from a series of images is labor-intensive and error-prone. Other researchers have devised chemical methods to reduce light scattering, making the tissue more transparent, but the resulting tissue is not accessible to fluorescent labeling molecules.

Deisseroth says that the main barrier to light penetration through biological tissues is scattering at the lipid boundaries that form structural membranes in and around cells. Lipids are also a problem because they interfere with the penetration of antibodies used to label specific molecules and identify cells. This is true of all biological tissue, he says, but lipid boundaries are particularly abundant in the brain. “But even though lipids are important structurally, and some lipids do have information in them, we think most of the interesting information in the brain is carried by proteins and nucleic acids,” he says. Removing the fat from the brain would preserve that information while allowing access to both light and macromolecules like antibodies. Unfortunately, removing lipids also destroys tissue structure and allow proteins to leak out. “So we knew we needed to build an infrastructure within the tissue,” Deisseroth says. His team, led by postdoctoral researcher Kwanghun Chung, experimented with various molecular supports structures, and settled on a hydrogel. Once the gel forms inside the tissue—capturing its proteins and genetic material—the lipids can be removed. The first step of CLARITY is to infuse tissue with hydrogel monomers—the building blocks of the gel—and chemically link them to the proteins, DNA, and RNA inside the tissue. Importantly, lipids do not bind to gel components and remain free. The infused tissue is heated, causing the gel monomers to link together into a three-dimensional network that supports the non-lipid components of the tissue. Finally, lipids are removed from the gel using strong detergents and an electrical current.

Brain tissue treated with CLARITY emerges from the process transparent and accessible to biological labeling molecules. With the lipid barriers gone, labeling antibodies permeated the porous hydrogel, enabling specific proteins and structures to be visualized under the microscope. Further, the hydrogel structure was stable enough to withstand the harsh treatments needed to remove those labels, meaning the researchers could reanalyze the same brain tissue with a focus on different proteins. When they tested CLARITY on clinical samples of postmortem human brain, the team had similar results. The technique successfully clarified a half-millimeter-thick sample of donated brain tissue from an autistic patient that had been stored in a brain bank for more than six years. Microscope imaging of the clarified block of brain tissue revealed that it contained some neurons that formed connections not only with neighboring cells, but also with themselves. It would be difficult to find and verify such an unusual structure using traditional methods, Deisseroth says. “If you had thin sections, it would be more challenging to be certain that you’d aligned things right. But with CLARITY, the tissue has never been taken apart, and we can look at it from many angles and with many different stains—so we can be confident of these unusual structures,” he says. Deisseroth says CLARITY will enable researchers to visualize the circuitry in the brain with a more global perspective than was previously possible, and could be particularly valuable when used to complement methods of manipulating neuronal activity, including optogenetics. He has created a website to share the technique—clarityresourcecenter.org—and says other labs are already finding useful applications of the technology, such as analyzing human tissue stored in brain banks and visualizing cancer cells within the three-dimensional context of a biopsy sample. Deisseroth’s lab will use CLARITY to enhance what they are learning about the activity of cells in the mouse brain, but, he says, the technique should be applicable to any tissue from any organism.

Howard Hughes Medical Institute
April 29, 2013

Original web page at Howard Hughes Medical Institute

Categories
News

World’s fastest camera used to detect rogue cancer cells

The ability to distinguish and isolate rare cells from among a large population of assorted cells has become increasingly important for the early detection of disease and for monitoring disease treatments. Circulating cancer tumor cells are a perfect example. Typically, there are only a handful of them among a billion healthy cells, yet they are precursors to metastasis, the spread of cancer that causes about 90 percent of cancer mortalities. Such “rogue” cells are not limited to cancer — they also include stem cells used for regenerative medicine and other cell types. Unfortunately, detecting such cells is difficult. Achieving good statistical accuracy requires an automated, high-throughput instrument that can examine millions of cells in a reasonably short time. Microscopes equipped with digital cameras are currently the gold standard for analyzing cells, but they are too slow to be useful for this application.

Now, a new optical microscope developed by UCLA engineers could make the tough task a whole lot easier. “To catch these elusive cells, the camera must be able to capture and digitally process millions of images continuously at a very high frame rate,” said Bahram Jalali, who holds the Northrop Grumman Endowed Opto-Electronic Chair in Electrical Engineering at the UCLA Henry Samueli School of Engineering and Applied Science. “Conventional CCD and CMOS cameras are not fast and sensitive enough. It takes time to read the data from the array of pixels, and they become less sensitive to light at high speed.” The current flow-cytometry method has high throughput, but since it relies on single-point light scattering, as opposed to taking a picture, it is not sensitive enough to detect very rare cell types, such as those present in early-stage or pre-metastasis cancer patients. To overcome these limitations, an interdisciplinary team of researchers led by Jalali and Dino Di Carlo, a UCLA associate professor of bioengineering, with expertise in optics and high-speed electronics, microfluidics, and biotechnology, has developed a high-throughput flow-through optical microscope with the ability to detect rare cells with sensitivity of one part per million in real time. This technology builds on the photonic time-stretch camera technology created by Jalali’s team in 2009 to produce the world’s fastest continuous-running camera. In the latest issue of the journal Proceedings of the National Academy of Sciences, Jalali, Di Carlo and their colleagues describe how they integrated this camera with advanced microfluidics and real-time image processing in order to classify cells in blood samples. The new blood-screening technology boasts a throughput of 100,000 cells per second, approximately 100 times higher than conventional imaging-based blood analyzers.

“This achievement required the integration of several cutting-edge technologies through collaborations between the departments of bioengineering and electrical engineering and the California NanoSystems Institute and adds to the significant technology infrastructure being developed at UCLA for cell-based diagnostics,” Di Carlo said. Both Jalali and Di Carlo are members of the California NanoSystems Institute at UCLA. Their research demonstrates real-time identification of rare breast cancer cells in blood with a record low false-positive rate of one cell in a million. Preliminary results indicate that this new technology has the potential to quickly enable the detection of rare circulating tumor cells from a large volume of blood, opening the way for statistically accurate early detection of cancer and for monitoring the efficiency of drug and radiation therapy. “This technology can significantly reduce errors and costs in medical diagnosis,” said lead author Keisuke Goda, a UCLA program manager in electrical engineering and bioengineering. The results were obtained by mixing cancer cells grown in a laboratory with blood in various proportions to emulate real-life patient blood.

Science Daily
July 24, 2012

Original web page at Science Daily

Categories
News

The elephant in the womb

Before giving birth to a 110-kilogram calf, mothers carry the fetus for 22 months, the longest gestation period of any mammal. And whereas most mammals have only one corpus luteum—a temporary gland that controls hormone levels during pregnancy—elephants have as many as 11. Now, by giving 17 elephants blood tests and ultrasound scans throughout their pregnancies, researchers have discovered a key to this remarkable form of motherhood. “The study is exciting, surprising, and very pleasing,” says veterinary researcher Twink Allen of the University of Cambridge in the United Kingdom, who was not involved in the work. “It’s a very unusual strategy the elephant seems to have adopted, and it has puzzled people for 30 or 40 years.” In most mammals, one corpus luteum forms from a single egg follicle in the ovary during each menstrual cycle. The temporary gland produces progesterone, which in turn promotes thickening of the endometrium and, if an egg is fertilized, maintains the correct balance of hormones throughout a pregnancy to ensure that a female’s body remains geared toward supporting her growing baby. If fertilization doesn’t occur, the corpus luteum dies, only to reform during the next reproductive cycle. From dissected animals, scientists have known for more than 50 years that elephant ovaries contain multiple corpora lutea. But they didn’t know how these structures formed or what roles they played in elephant pregnancies. And they’d never studied the corpus lutea in real-time during an elephant’s life or pregnancy.

“There were all sorts of theories put forth,” says Imke Lueders of the Leibniz Institute for Zoo and Wildlife Research in Berlin. “Some people thought that elephants accumulated the corpora lutea over many cycles, for example. Nobody could really prove any of the theories because elephants are so hard to study.” Hoping to change this, Lueders developed a method to follow elephant pregnancies using protocols originally designed for horses. She collaborated with researchers and zoos around the world to study 15 female Asian elephants and two female African elephants over a 5-year period. During normal menstrual cycles before pregnancies, as well as throughout the entire course of each female’s pregnancy, the scientists took blood samples and performed ultrasounds. They used rectally inserted ultrasound probes on the elephants, which had to be specially trained not to kick and rear up during the uncomfortable exams. The researchers found that the animals formed, on average, five corpora lutea during each menstrual cycle. And surprisingly, whereas one corpus luteum was derived from an egg-generating follicle, as happens in mammals such as humans, the rest of the structures formed from separate follicles at a different point in the reproductive cycle.

Over the course of each pregnancy, each gland slowly decreased its progesterone production. Having many glands likely helps keep the levels above a threshold for the entire 22 month gestation, the team reports online today in the Proceedings of the Royal Society B. The scientists hypothesize that the long gestation period allows for full brain development of elephants, which are born with complex cognitive skills and are immediately able to sense how to survive in their environment and interact with the herd. “We still don’t understand everything,” Lueders says. “We’d like to look in more detail at the molecular aspects of this next. What genes are expressed in the ovaries that cause this?” She also wants to study whether the finding holds true in manatees, a close relative of elephants. The observation explains a curiosity about elephant reproduction, says Allen. But it also could lead to methods for controlling elephant ovulation or timing artificial insemination. Such methods could come in handy when zoos are trying to breed animals—especially those that rarely mate and become pregnant on their own. But they also could help researchers develop elephant birth control for areas plagued by elephant overpopulation, he says.

ScienceNow
July 10, 2012

Original web page at ScienceNow

Categories
News

Groundbreaking new graphene-based MRI contrast agent

Dr. Balaji Sitharaman, PhD, an Assistant Professor in the Department of Biomedical Engineering at Stony Brook University, and a team of researchers developed a new, highly efficacious, potentially safer and more cost effective nanoparticle-based MRI (magnetic resonance imaging) contrast agent for improved disease diagnosis and detection. The most recent findings are discussed in detail in his team’s research paper “Physicochemical characterization, and relaxometry studies of micro-graphite oxide, graphene nanoplatelets, and nanoribbons,” published in the June 7 edition of the journal PLoS ONE. The MRI, the technology for which was invented at Stony Brook University by Professor Paul Lauterbur, is one of the most powerful and central techniques in diagnostic medicine and biomedical research used primarily to render anatomical details for improved diagnosis of many pathologies and diseases. Currently, most MRI procedures use gadolinium-based contrast agents to improve the visibility and definition of disease detection. However, recent studies have shown harmful side effects, such as nephrogenic systemic fibrosis, stemming from the use of this contrast agent in some patients, forcing the Food and Drug Administration (FDA) to place restrictions on the clinical use of gadolinium. Further, most MRI contrast agents are not suitable for extended-residence-intravascular (blood pool), or tissue (organ)-specific imaging, and do not allow molecular imaging.

To address the need for an MRI contrast agent that demonstrates greater effectiveness and lower toxicity, Dr. Sitharaman developed a novel high-performance graphene-based contrast agent that may replace the gadolinium-based agent which is widely used by physicians today. “A graphene-based contrast agent can allow the same clinical MRI performance at substantially lower dosages,” said Dr. Sitharaman. The project is a Wallace H. Coulter Foundation Translational Research Award winner and the recipient of a two-year translational grant to study preclinical safety and efficacy. “The technology will lower health care costs by reducing the cost per dose as well as the number of doses required,” noted Dr. Sitharaman. “Further, since this new MRI contrast agent will substantially improve disease detection by increasing sensitivity and diagnostic confidence, it will enable earlier treatment for many diseases, which is less expensive, and of course more effective for diseases such as cancer.”

Science Daily
June 26, 2012

Original web page at Science Daily

Categories
News

New sensory organ found in rorqual whales

Scientists at the University of British Columbia and the Smithsonian Institution have discovered a sensory organ in rorqual whales that coordinates its signature lunge-feeding behaviour — and may help explain their enormous size. Rorquals are a subgroup of baleen whales — including blue, fin, minke and humpback whales. They are characterized by a special, accordion-like blubber layer that goes from the snout to the navel. The blubber expands up to several times its resting length to allow the whales to engulf large quantities of prey-laden water, which is then expelled through the baleen to filter krill and fish. The study, to be featured on the cover of the journal Nature, details the discovery of an organ at the tip of the whale’s chin, lodged in the ligamentous tissue that connects their two jaws. Samples were collected from recently deceased fin and minke whale carcasses captured as part of Icelandic commercial whaling operations. Commercial whaling in Iceland resumed in 2006 and quotas are determined annually by its government. Scanning of the whale’s chin revealed a grape fruit-sized sensory organ, located between the tips of the jaws, and supplied by neurovascular tissue.

The research team was assisted by technicians at FPInnovations, the owner of Canada’s only X-ray computed tomography (XRCT) machine large enough to accommodate the massive specimens. Used to scan giant logs, the XRCT machine provides a three dimensional map of the internal structure of whale tissues. “We think this sensory organ sends information to the brain in order to coordinate the complex mechanism of lunge-feeding, which involves rotating the jaws, inverting the tongue and expanding the throat pleats and blubber layer,” says lead author Nick Pyenson, a paleobiologist at the Smithsonian Institution, who conducted the study while a postdoctoral fellow at UBC. “It probably helps rorquals feel prey density when initiating a lunge.” A fin whale, the second longest whale on the planet, can engulf as much as 80 cubic metres of water and prey — equal or greater than the size of the whale itself — in each gulp in less than six seconds. A previous study by co-author Jeremy Goldbogen showed that a fin whale captures 10 kilograms of krill in each gulp in order to sustain its average 50-ton body mass. “In terms of evolution, the innovation of this sensory organ has a fundamental role in one of the most extreme feeding methods of aquatic creatures,” says co-author and UBC Zoology Prof. Bob Shadwick. “Because the physical features required to carry out lunge-feeding evolved before the extremely large body sizes observed in today’s rorquals, it’s likely that this sensory organ — and its role in coordinating successful lunging — is responsible for rorquals claiming the largest-animals-on-earth status,” Shadwick adds. “This also demonstrates how poorly we understand the basic functions of these top predators of the ocean and underlines the importance for biodiversity conservation.”

Science Daily
June 12, 2012

Original web page at Science Daily

Categories
News

What is your dog thinking? Brain scans unleash canine secrets

When your dog gazes up at you adoringly, what does it see? A best friend? A pack leader? A can opener? Many dog lovers make all kinds of inferences about how their pets feel about them, but no one has captured images of actual canine thought processes — until now. Emory University researchers have developed a new methodology to scan the brains of alert dogs and explore the minds of the oldest domesticated species. The technique uses harmless functional Magnetic Resonance Imaging (fMRI), the same tool that is unlocking secrets of the human brain. The Public Library of Science (PLoS ONE) is publishing the results of their first experiment, showing how the brains of dogs reacted to hand signals given by their owners. “It was amazing to see the first brain images of a fully awake, unrestrained dog,” says Gregory Berns, director of the Emory Center for Neuropolicy and lead researcher of the dog project. “As far as we know, no one has been able to do this previously. We hope this opens up a whole new door for understanding canine cognition and inter-species communication. We want to understand the dog-human relationship, from the dog’s perspective.”

Two dogs are involved in the first phase of the project. Callie is a two-year-old Feist, or southern squirrel-hunting dog. Berns adopted her at nine months from a shelter. McKenzie is a three-year-old Border Collie, who was already well-trained in agility competition by her owner, Melissa Cate. Both dogs were trained over several months to walk into an fMRI scanner and hold completely still while researchers measured their neural activity. The researchers aim to decode the mental processes of dogs by recording which areas of their brains are activated by various stimuli. Ultimately, they hope to get at questions like: Do dogs have empathy? Do they know when their owners are happy or sad? How much language do they really understand? In the first experiment, the dogs were trained to respond to hand signals. One signal meant the dog would receive a hot dog treat, and another signal meant it would not receive one. The caudate region of the brain, associated with rewards in humans, showed activation in both dogs when they saw the signal for the treat, but not for the no-treat signal. “These results indicate that dogs pay very close attention to human signals,” Berns says. “And these signals may have a direct line to the dog’s reward system.” Berns is a neuroeconomist, who normally uses fMRI technology to study how the human mind works. His human brain-imaging studies have looked at everything from why teens engage in risky behavior to how adults decide to follow, or break, established rules of society.

Dog lovers may not need convincing on the merits of researching the minds of our canine companions. “To the skeptics out there, and the cat people, I would say that dogs are the first domesticated species, going back at least 10,000 years, and by some estimates 30,000 years,” Berns says. “The dog’s brain represents something special about how humans and animals came together. It’s possible that dogs have even affected human evolution. People who took dogs into their homes and villages may have had certain advantages. As much as we made dogs, I think dogs probably made some part of us, too.” The idea for the dog project came to Berns about a year ago, when he learned that a U.S. Navy dog had been a member of the SEAL team that killed Osama bin Laden. “I was amazed when I saw the pictures of what military dogs can do,” Berns says. “I realized that if dogs can be trained to jump out of helicopters and airplanes, we could certainly train them to go into an fMRI to see what they’re thinking.”

All procedures for the dog project were approved by the Institutional Animal Care and Use Committee of Emory. “From the outset, we wanted to ensure the safety and comfort of the dogs,” Berns says. “We wanted them to be unrestrained and go into the scanner willingly.” The dogs were trained to wear earmuffs, to protect them from the noise of the scanner. They were also taught to hold their heads perfectly still on a chin rest during the scanning process, to prevent blurring of the images. “We know the dogs are happy by their body language,” says Mark Spivak, the professional trainer involved in the project. Callie, in particular, seems to revel in the attention of breaking new ground in science. “She enters the scanner on her own, without a command, sometimes when it’s not her turn,” Spivak says. “She’s eager to participate.”

Science Daily
May 15, 2012

Original web page at Science Daily

Categories
News

Sharp images from the living mouse brain

To explore the most intricate structures of the brain in order to decipher how it functions — Stefan Hell’s team of researchers at the Max Planck Institute for Biophysical Chemistry in Göttingen has made a significant step closer to this goal. Using the STED microscopy developed by Hell, the scientists have, for the first time, managed to record detailed live images inside the brain of a living mouse. Captured in the previously impossible resolution of less than 70 nanometers, these images have made the minute structures visible which allow nerve cells to communicate with each other. This application of STED microscopy opens up numerous new possibilities for neuroscientists to decode fundamental processes in the brain Every day a huge quantity of information travels not only over our information superhighways; our brain must process an enormous amount of data as well. In order to do this, each of the approximately hundred billion nerve cells establishes contact with thousands of neighboring nerve cells. The entire data exchange takes place via contact sites — the synapses. Only if the nerve cells communicate via such contact sites at the right time and at the right place can the brain master its complex tasks: We play a difficult piece of piano, learn to juggle, or remember the names of people we have not seen for years.

We can learn most about these important contact sites in the brain by observing them at work. When and where do new synapses form and why do they disappear elsewhere? This is not easy to determine, since details in living nerve cells can only be observed with optical microscopes. Due to the diffraction of light, however, structures located closer together than 200 nanometers (200 millionths of a millimeter) appear as a single blurred spot. The STED microscopy developed by Stefan Hell and his team at the Max Planck Institute for Biophysical Chemistry is a groundbreaking method devised to surpass this resolution limit. They use a simple trick: Closely-positioned elements are kept dark under a special laser beam so that they emit fluorescence sequentially one after the other, rather than simultaneously, and can therefore be distinguished. Using this technique, Hell’s team has been able to increase the resolution by approximately tenfold compared to conventional optical microscopes. STED microscopy has already found wide application in fields ranging from materials research to cell biology. Under this microscope, cell cultures and histological preparations have offered unique insights into the cellular nanocosmos. The first real-time video clips from the interior of a nerve cell have demonstrated how tiny transmitter vesicles migrate within the long nerve cell endings.

What was only an ambitious vision a year ago has now become reality: to also study higher living organisms at this sharp resolution in the nanometer range. By looking directly into the brains of living mice using a STED microscope, Hell and his team were the first ones to image nerve cells in the upper brain layer of the rodent with resolution far beyond the diffraction limit. “With our STED microscope we can clearly see the very fine dendritic structures of nerve cells at which the synapses are located in the brain of a living mouse. At a resolution of 70 nanometers, we easily recognize these so-called dendritic spines with their mushroom- or button-shaped heads,” explains Hell. They are the clearest images of these fundamental contact sites in the brain to date. “To make these visible, we take genetically modified mice that produce large quantities of a yellow fluorescing protein in their nerve cells. This protein migrates into all the branches of the nerve cell, even into smallest, finest structures,” adds Katrin Willig, a postdoctoral researcher in Hell’s department. The genetically modified mice for these experiments originated from the group of Frank Kirchhoff at the Göttingen Max Planck Institute for Experimental Medicine. Images of the nerve cells taken seven to eight minutes apart revealed something surprising: The dendritic spine heads move and change their shape. “In the future, these super-sharp live images could even show how certain proteins are distributed at the contact points,” adds Hell. With such increasingly detailed images of structures in the brain, Hell’s team hopes to shed light onto the composition and function of the synapses on the molecular level.

Such insights could also help to better understand illnesses that are caused by synapse malfunction. Among these so-called synaptopathies are, for example, autism and epilepsy. As Hell explains, “Through STED microscopy and its application in living organisms, we should now be able to gain optical access of such illnesses on the molecular scale for the first time.” As one of the two representatives of the Göttingen Research Center Molecular Physiology of the Brain funded by the German Research Foundation, he is committed to collaboration in his further research. Together with neurobiologists and neurologists, he and his team plan to transfer the progress made in imaging technology into fundamental knowledge about the functioning of our brains.

Science Daily
February 21, 2012

Original web page at Science Daily

Categories
News

Engineered bacteria effectively target tumors, enabling tumor imaging potential in mice

Tumor-targeted bioluminescent bacteria have been shown for the first time to provide accurate 3-D images of tumors in mice, further advancing the potential for targeted cancer drug delivery, according to a study published in the Jan. 25 issue of the online journal PLoS ONE. The specially engineered probiotic bacteria, like those found in many yogurts, were intravenously injected into mice with tumors, after which the researchers took full body bioluminescent images. The 3-D images revealed information about the number and location of the bacteria, to the level of precisely revealing where within the tumor the bacteria were living, providing much more information on the interaction of bacteria and tumors than was previously available using similar two-dimensional imaging methods. According to the authors, led by Mark Tangney of University College Cork in Ireland, “before now, researchers used luminescence to provide an approximation of where a test organism was within the body, and would then follow up with multiple further experiments using different techniques to try to find a precise location.” This new research suggests that such bacteria can be engineered to contain diagnostic or therapeutic agents that would be produced specifically within the tumor for targeted treatment.

Science Daily
February 7, 2012

Original web page at Science Daily

Categories
News

Form and function: New MRI technique to diagnose or rule out Alzheimer’s disease

On the quest for safe, reliable and accessible tools to accurately diagnose Alzheimer’s disease, researchers from the Perelman School of Medicine at the University of Pennsylvania found a new way of diagnosing and tracking Alzheimer’s disease, using an innovative magnetic resonance imaging (MRI) technique called arterial spin labeling (ASL) to measure changes in brain function. The team determined that the ASL-MRI test is a promising alternative to the current standard, a specific PET scan that requires exposure to small amounts of a radioactive glucose analog and costs approximately four-times more than an ASL-MRI. Two studies now appear in Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association and Neurology. ASL-MRI can be used to measure neurodegenerative changes in a similar way that fluorodeoxyglucose Positron emission tomography (FDG-PET) scans are currently being used to measure glucose metabolism in the brain. Both tests correlate with cognitive decline in patients with Alzheimer’s disease. “In brain tissue, regional blood flow is tightly coupled to regional glucose consumption, which is the fuel the brain uses to function. Increases or decreases in brain function are accompanied by changes in both blood flow and glucose metabolism,” explained John A. Detre, MD, professor of Neurology and Radiology at Penn, senior author on the papers, who has worked on ASL-MRI for the past 20 years. “We designed ASL-MRI to allow cerebral blood flow to be imaged noninvasively and quantitatively using a routine MRI scanner.”

When Alzheimer’s disease is suspected, patients typically receive an MRI initially to look for structural changes that could indicate other medical causes, such as a stroke or brain tumor. Adding about 10-20 minutes to the test time, ASL can be incorporated into the routine MRI and capture functional measures to detect Alzheimer’s disease upfront, turning a routine clinical test (structural MRI) into both a structural and functional test. “If ASL-MRI were included in the initial diagnostic work-up routinely, it would save the time for obtaining an additional PET scan, which we often will order when there is diagnostic uncertainty, and would potentially speed up diagnosis,” said David Wolk, MD, Assistant Professor of Neurology and Assistant Director of the Penn Memory Center, and a collaborator on this research. The studies being reported this week show a comparison of ASL-MRI and FDG-PET in a group of Alzhiemer’s patients and age-matched controls. Cerebral blood flow and glucose metabolism were measured simultaneously by injecting the PET tracer during the MRI study. The data were then analyzed two different ways.

In the first study, now online in Alzheimer’s and Dementia, ASL-MRI and FDG-PET images from 13 patients diagnosed with Alzheimer’s and 18 age-matched controls were analyzed by visual inspection. Independent, blinded review of the two tests by expert nuclear medicine physicians demonstrated similar abilities to rule out (sensitivity) and diagnose (specificity) Alzheimer’s. Neither ASL-MRI nor FDG-PET showed a clear advantage from quantitative testing. In the second study, published in Neurology, the ASL-MRI and FDG-PET images were compared statistically at each location in the brain by computerized analysis. Data from 15 AD patients were compared to 19 age-matched healthy adults. The patterns of reduction in cerebral blood flow were nearly identical to the patterns of reduced glucose metabolism by FDG-PET, both of which differed from the patterns of reduction in gray matter seen in AD. “Given that ASL-MRI is entirely non-invasive, has no radiation exposure, is widely available and easily incorporated into standard MRI routines, it is potentially more suitable for screening and longitudinal disease tracking than FDG-PET,” said the Neurology study authors.

Science Daily
December 13, 2011

Original web page at Science Daily

Categories
News

Newly developed fluorescent protein makes internal organs visible

Researchers at Albert Einstein College of Medicine of Yeshiva University have developed the first fluorescent protein that enables scientists to clearly “see” the internal organs of living animals without the need for a scalpel or imaging techniques that can have side effects or increase radiation exposure. The new probe could prove to be a breakthrough in whole-body imaging — allowing doctors, for example, to noninvasively monitor the growth of tumors in order to assess the effectiveness of anti-cancer therapies. In contrast to other body-scanning techniques, fluorescent-protein imaging does not involve radiation exposure or require the use of contrast agents. The findings are described in the July 17 online edition of Nature Biotechnology. For the past 20 years, scientists have used a variety of colored fluorescent proteins, derived from jellyfish and corals, to visualize cells and their organelles and molecules. But using fluorescent probes to peer inside live mammals has posed a major challenge. The reason: hemoglobin in an animal’s blood effectively absorbs the blue, green, red and other wavelengths used to stimulate standard fluorescent proteins along with any wavelengths emitted by the proteins when they do light up.

To overcome that roadblock, the laboratory of Vladislav Verkhusha, Ph.D., associate professor of anatomy and structural biology at Einstein and the study’s senior author, engineered a fluorescent protein from a bacterial phytochrome (the pigment that a species of bacteria uses to detect light). This new phytochrome-based fluorescent protein, dubbed iRFP, both absorbs and emits light in the near-infrared portion of the electromagnetic spectrum- the spectral region in which mammalian tissues are nearly transparent. The researchers targeted their fluorescent protein to the liver — an organ particularly difficult to visualize because of its high blood content. Adenovirus particles containing the gene for iRFP were injected into mice. Once the viruses and their gene cargoes infected liver cells, the infected cells expressed the gene and produced iRFP protein. The mice were then exposed to near-infrared light and it was possible to visualize the resulting emitted fluorescent light using a whole-body imaging device. Fluorescence of the liver in the infected mice was first detected the second day after infection and reached a peak at day five. Additional experiments showed that the iRFP fluorescent protein was nontoxic.

“Our study found that iRFP was far superior to the other fluorescent proteins that reportedly help in visualizing the livers of live animals,” said Grigory Filonov, Ph.D., a postdoctoral fellow in Dr. Verkhusha’s laboratory at Einstein, and the first author of the Nature Biotechnology paper. “iRFP not only produced a far brighter image, with higher contrast than the other fluorescent proteins, but was also very stable over time. We believe it will significantly broaden the potential uses for noninvasive whole-body imaging.” Dr. Filonov noted that fluorescent-protein imaging involves no radiation risk, which can occur with standard x-rays and computed tomography (CT) scanning. And unlike magnetic resonance imaging (MRI), in which contrasting agents must sometimes be swallowed or injected to make internal body structures more visible, the contrast provided by iRFP is so vibrant that contrasting agents are not needed.

Science Daily
August 9, 2011

Original web page at Science Daily

Categories
News

Imaging animals for better research

CT scans are one technique that can help reduce the number of animals used in research. Scientists are increasingly turning to non-invasive imaging to further the ‘3Rs’ of work in animals — replacement, refinement and reduction. Although the use of animals in modern medicine and biology is essential, researchers are actively working to reduce the numbers used and improve on how they are used. Medical technologies, such as computed tomography (CT) scans and magnetic resonance imaging (MRI), together with imaging techniques specific to biology, can assist in this. “The big trend is combining all the available techniques together in the same animal, increasing the amount of information we get out of the subject,” says François Lassailly, a biologist specializing in imaging at the Cancer Research UK London Research Institute (LRI). “This is beneficial to the animals and beneficial to the science.” For example, he told a conference in London last week, if you want to investigate disease progression in an animal model, you would normally have to sacrifice a few of your study group every week or so. But by using imaging, you can look at disease progression through the lifetimes of individual animals and thus drastically reduce the number used. Imaging also offers the possibility of looking at several biomarkers at once, thereby answering more questions in a single experiment.

With Lassailly’s help, teams at the LRI are using micro-CT to detect lung tumours in animals. They are also using optical imaging, for example with cancer cells that have been engineered to emit light to image tumours inside animal subjects. A key concept, says Lassailly, is that researchers should be treating an ‘ani-patient’ — so that the study of the animal mimics the treatment of a patient in the clinic. This includes applying all the scanning and imaging techniques to which a hospital doctor would have access and thus bridging the gap between the laboratory and the clinic. Sally Sharpe, a senior immunologist at the Health Protection Agency’s Porton Down research site, also presented her latest work. This involves using MRI and CT scans to improve the relevance of animal models of infectious diseases, particularly with regard to drugs and vaccines for tuberculosis. So far, her team has shown that images can be collected from live animals, and that CT and MRI images of tissue collected from infected individuals are useful not just for visualizing the disease, but also for quantifying the degree to which progression or protection has occurred. “For example, we have compared the diagnostic sensitivity of X-ray images with CT and MRI images of some individuals. Where the individual is giving a normal X-ray, the disease can be picked up by MRI and CT,” she says.

Now the team is investigating whether it can collect useful images from infected animals kept under isolation conditions. For this, the researchers use a device Sharpe likens to a sealed baby incubator, ventilated by means of high-efficiency filters. This work could allow the efficacy of treatments for the disease and vaccines to be established more quickly. “If you can get better data, there is less chance that you need to repeat experiments, and you can get more information from fewer animals,” she adds. “It would be an amazing refinement if we were able to track this disease in living animals.”

Nature
July 12, 2011

Original web page at Nature

Categories
News

New MRI methodology revolutionizes imaging of the beating heart

Scientists of the Charité — Universitätsmedizin Berlin and the Max-Delbrück-Center for Molecular Medicine (MDC) Berlin-Buch have developed a highly efficient approach for imaging the beating human heart. The images produced in one of the world’s most powerful MRI (magnetic resonance imaging) systems whose power is equivalent to 150,000 times Earth’s magnetic field are of a much higher detail than cardiac images commonly generated in current clinical practice. The ultra-high field approach permits a superb delineation between blood and heart muscle. Even subtle anatomical structures are made clearly visible. The new procedure holds the promise to advance the capabilities of cardiac research and care as cardiac malfunctions can be diagnosed, treated and monitored at a much earlier point in disease progression.

For cardiac imaging in ultrahigh fields new versions of multi-channel transmit and receive antennas — so-called radiofrequency coils — were developed at the Berlin Ultrahigh Field Facility (B.U.F.F.) located at Campus Buch. For this purpose a joint collaboration between the Charité, the MDC, the German Metrology Institute and Siemens Healthcare was initiated. To make use of the capacity and traits of the strong magnetic field a groundbreaking triggering device was developed to synchronize cardiac imaging with heart motion. This approach eliminates mis-synchronization frequently encountered with conventional triggering devices and hence helps to generate crisp cardiac images, a feature which might be compared with sport macros used in digital photography.

“We correlate the image exposure with the heartbeat” explains the investigator of the study Prof. Thoralf Niendorf, whose work is published in the March issue of the Journal for Magnetic Resonance Imaging. “Our procedure is immune to interference with strong magnetic fields so that we can compensate for the motion of the heart which results in high image quality free of cardiac motion induced blurring and artifacts.” The Berlin-based team led by Professor Thoralf Niendorf, Prof. Jeanette Schulz-Menger from the Charité and Dr. Bernd Ittermann from the German Metrology Institute used the new technologies to derive for the first time a clearly defined image of the beating heart in a magnetic field with a strength of 7.0 Tesla. The advancement in imaging technology culminated in images of the beating heart with a spatial resolution which is by far superior to that previously available and which might come close to turning a 10 megapixel digital camera into a 50 megapixel digital camera. The novel technology tailored for cardiac MRI together with the quality of the anatomical and functional images have created excitement among the international imaging community. The first clinical results and experiences were very encouraging, the researchers say, and are the driving force for broader clinical studies.

Science Daily
May 3, 2011

Original web page at Science Daily